Investigator Agreement Template for Canada

An Investigator Agreement is a comprehensive legal contract that governs the relationship between clinical trial sponsors and investigators conducting research studies in Canada. This document establishes clear responsibilities, regulatory compliance requirements, and operational guidelines to ensure your clinical research meets Canadian standards while protecting all parties involved.

When do you need this document?

You need an Investigator Agreement whenever you're initiating a clinical trial in Canada that involves multiple parties. This includes situations where pharmaceutical companies engage hospitals or research institutions to conduct drug trials, when contract research organizations coordinate multi-site studies, or when medical device companies partner with healthcare facilities for clinical testing. The agreement is also essential when establishing relationships between principal investigators and sub-investigators, ensuring clear chains of responsibility and compliance. Any research involving human subjects that requires Health Canada approval or ethics board review will typically require this foundational document.

Key legal considerations

Your Investigator Agreement must address several critical legal elements to protect all parties and ensure regulatory compliance. The scope of work section should detail specific investigator responsibilities, including patient recruitment, protocol adherence, and adverse event reporting requirements. Compliance clauses must reference Health Canada regulations, ICH-GCP guidelines, and provincial healthcare laws. Financial terms should clearly outline payment structures, expense reimbursement, and audit rights. Intellectual property provisions need to address data ownership, publication rights, and patent considerations under the Patent Act. The agreement should also include robust confidentiality clauses to protect proprietary information and patient privacy under PIPEDA requirements. Indemnification and liability allocation clauses are crucial for managing risks associated with clinical research activities.

Legal requirements in Canada

Canadian Investigator Agreements must comply with the Food and Drugs Act and related regulations governing clinical trials. Your agreement must ensure adherence to Health Canada's ICH Guidelines for Good Clinical Practice, which establish ethical and scientific quality standards. Privacy protection requires compliance with PIPEDA for personal information handling and provincial privacy legislation where applicable. The agreement must reference the Tri-Council Policy Statement (TCPS 2) for ethical conduct standards when involving human subjects. Intellectual property provisions should align with the Patent Act for invention rights and data ownership. Provincial healthcare regulations may impose additional requirements depending on the trial location and institutional affiliations. Ethics review board approval processes must be incorporated into the agreement structure, ensuring proper oversight and compliance monitoring throughout the study duration.